Rakovina Therapeutics plans to showcase AI-driven drug discovery progress at industry conference.

From GlobeNewswire: 2025-01-03 16:30:00

Rakovina Therapeutics, Inc. (TSX: RKV) will participate in events and meetings alongside the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco from January 13-16, 2025. The company aims to showcase its progress in AI-driven drug discovery and advancements in cancer treatment through meetings with industry leaders, potential collaborators, and investors. In 2025, Rakovina plans to advance its AI-identified drug candidates through preclinical validation for entry into clinical trials and enhance its AI-driven platforms for streamlining drug discovery. The company also announced the grant of 4,330,00 stock options to certain officers and directors.



Read more at GlobeNewswire: Rakovina Therapeutics to Connect with Industry Leaders